Fernández-Ruiz L, Ariza-Jiménez AB, De CC

Language: Spanish
References: 16
Page: 232-235
PDF size: 221.28 Kb.

ABSTRACT

Neonatal diabetes mellitus (NMD) usually onset before six months of life, which can be permanent or transitory. Currently, more than 20 genetic causes are known that determine its phenotypic and treatment variability. Presentation of two clinical cases: The first case was a newborn with a diagnosis of transient DMN, in whom hyperglycemia was an accidental finding. A mutation was identified in one gene which encodes some subunities of the ATP-sensitive K channel (KATP). This patient had a good response to glibenclamide. The second newborn developed a transient NMD secondary to a 6q24 mutation, but this patient also presented aortic coarctation, urinary tract and brain malformations. The hyperglycemia was treated with insulin. Conclusions: These two cases illustrate the variability that can occur in DMN, both with different evolution and therapeutic management, as well as the need of molecular genetics for diagnosis and treatment.

REFERENCES

1. Rubio-Cabezas O, Ellard S. Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options. Horm Res Paediatr. 2013; 80(3): 137-146.

2. Letourneau LR, Carmody D, Wroblewski K, Denson AM, Sanyoura M, Naylor RN et al. Diabetes presentation in infancy: high risk of diabetic ketoacidosis. Diabetes Care. 2017; 40(10): e147-e148.

3. Gálvez-López AG, Villalobos-Lizardi JC, Águila-Cano R. Diabetes neonatal monogénica. Rev Med MD. 2018; 10(1): 29-34.

4. Hay WW, Rozance PJ. Neonatal hyperglycemia: causes, treatments, and cautions. J Pediatr. 2018; 200: 6-8.

5. Karges B, Meissner T, Icks A, Kapellen T, Holl RW. Management of diabetes mellitus in infants. Nat Rev Endocrinol. 2012; 8: 201-211.

6. Lemelman MB, Letourneau L, Greeley SAW. Neonatal diabetes mellitus: an update on diagnosis and management. Clin Perinatol. 2018; 45(1): 41-59.

7. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R et al. Activating mutations in the ABBC8 gene in neonatal diabetes mellitus. N Engl J Med. 2006; 355: 456-466.

8. McTaggart JS, Clark RH, Ashcroft FM. The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet. J Physiol. 2010; 588(17): 3201-3209.

9. De Franco E, Flanagan SE, Houghton JAL, Allen HL, MacKay DJG, Temple IK et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015; 386(9997): 957-963.

10. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care. 2008; 31(2): 204-209.

11. Mackay DJG, Boonen SE, Clayton-Smith J, Goodship J, Hahnemann JMD, Kant SG et al. A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet. 2006; 120: 262-269.

12. Polak M, Cavé H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis. 2007; 2(1): 1-11.

13. Docherty LE, Kabwama S, Lehmann A, Hawke E, Harrison L, Flanagan SE et al. Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients. Diabetologia. 2013; 56(4): 758-762.

14. Gore RH, Nikita ME, Newton PG, Carter RG, Reyes-Bautista J, Greene CL. Duplication 6q24: more than just diabetes. J Endocr Soc. 2020; 4(5): 6-9.

15. Ferraro M, Ramos O, Asenjo S, García H, Lema A, Blanco M et al. DN ¿Transitoria o definitiva? Asoc Latinoam Diabetes. 2007; 15(2): 55-59.

16. Jiménez-Uscanga RD, Ordóñez-Gutiérrez E, Jiménez-Urueta P, Gómez-Guillermoprieto L. Diabetes mellitus neonatal. Seguimiento a largo plazo de un paciente. Acta Pediatr Mex. 2010; 31(6): 274-280.